Repligen’s $200 Million Acquisition of ARTeSYN Biosolutions

Arthur Cox and Goodwin represented Repligen Corporation on the transaction. Repligen, a life sciences company focused on bioprocessing technology leadership, agreed to acquire ARTeSYN Biosolutions for…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here